Herbal And Ayurvedic Trends In India And Beyond Will Thrive

Key Takeaways

• Market share gains and strong demand across categories, along with health and wellness trends, strengthen Dabur's pricing power and revenue growth outlook.
  
• International expansion and ongoing innovation reduce reliance on India, enhance earnings stability, and support margin improvement despite inflationary pressures.
  
• Heightened competition, stagnating core segments, weather-driven revenue risks, reduced disclosure, and persistent input inflation all threaten sustained margin and earnings growth.

Catalysts

Operates as a fast moving consumer goods company worldwide.

• Continued strong rural and urban demand recovery, coupled with market share gains across key categories (oral care, home care, skin care), positions Dabur to capitalize on India's rising disposable incomes and urbanization, supporting robust future revenue growth.
  
• Sustained consumer shift toward Ayurvedic, herbal, and natural products underpins outperformance of the Red franchise and the herbal toothpaste segment, reinforcing Dabur's pricing power and margin potential as health and wellness trends deepen.
  
• Significant momentum in international markets (double-digit growth across MENA, Sub-Saharan Africa, US, Europe, Turkey, and Bangladesh) is driving revenue diversification and is likely to reduce dependency on the Indian market, enhancing earnings stability.
  
• Ongoing innovation and premiumization-such as expansion into premium variants (Sundarbans and Organic Honey, Real Activ, Health Juices, modernized Hajmola, and Pudin Hara formats)-are expected to improve margins and average selling prices, with management signaling material operating margin improvement for the full year.
  
• Continued investment in brand-building, supply chain savings, and cost initiatives enables Dabur to offset inflationary pressures, maintain or increase operating margins, and support steady long-term net profit growth.

Dabur India Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Dabur India's revenue will grow by 9.1% annually over the next 3 years.
• Analysts assume that profit margins will increase from 14.1% today to 15.4% in 3 years time.
• Analysts expect earnings to reach ₹25.3 billion (and earnings per share of ₹14.26) by about September 2028, up from ₹17.8 billion today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 57.5x on those 2028 earnings, up from 54.1x today. This future PE is lower than the current PE for the IN Personal Products industry at 58.5x.
• Analysts expect the number of shares outstanding to grow by 0.07% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 14.12%, as per the Simply Wall St company report.

Dabur India Future Earnings Per Share Growth

Risks

• Competitive intensity, especially in key categories like Oral Care and Hair Oils, is leading to higher promotional spending and price discounting (e.g., net realization was -1.8% in India), which could continue to squeeze margins if deep-pocketed MNCs and regional players maintain aggressive strategies-risking both net margins and revenue growth.
  
• Stagnation in high-margin health care segments (e.g., Honey and Chyawanprash), with management acknowledging a multi-year struggle to surpass the post-COVID base, signals a risk that core categories may have limited long-term growth potential if younger consumers do not adopt these products, impacting overall revenue and margin expansion.
  
• Heavy weather-dependency in the beverages and seasonal portfolio (e.g., significant impact from unseasonal rainfall leading to 30–40% declines in Glucose and Juice sales) exposes Dabur's topline to increased volatility due to climate change and unpredictable weather patterns, which could undermine consistent revenue growth.
  
• The company's recent decline in disclosure transparency (noted by investors on the call) could erode market confidence and investor trust, potentially suppressing share price due to perceived governance risks or uncertainty regarding underlying financial performance, particularly if volume and primary vs. secondary sales data are less freely reported.
  
• Inflationary pressures-particularly in raw materials like edible oils and Amla-are persistently high (projected at 7–8%), making Dabur reliant on continual price increases and cost-saving initiatives to protect gross and operating margins; failure to do so in the face of strong competition, or customer resistance to price hikes, poses a risk to both margins and long-term earnings growth.

Valuation

• The analysts have a consensus price target of ₹550.3 for Dabur India based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹630.0, and the most bearish reporting a price target of just ₹400.0.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ₹163.8 billion, earnings will come to ₹25.3 billion, and it would be trading on a PE ratio of 57.5x, assuming you use a discount rate of 14.1%.
• Given the current share price of ₹543.5, the analyst price target of ₹550.3 is 1.2% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.